Organogenesis Holdings Inc. ORGO Gain/Loss on Asset Sales
Gain/Loss on Asset Sales at other companies
Other financials
Where this comes from
Reported directly by Organogenesis Holdings Inc. in its filing.
Tagged under the XBRL concept us-gaap:GainLossOnSaleOfPropertyPlantEquipment.
The official record: Organogenesis Holdings Inc.’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Organogenesis Holdings Inc.'s gain/loss on asset sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Organogenesis Holdings Inc.'s gain/loss on asset sales?
- Organogenesis Holdings Inc. (ORGO) reported gain/loss on asset sales of -$115K in Q4 2025.
- How has Organogenesis Holdings Inc.'s gain/loss on asset sales changed year-over-year?
- Organogenesis Holdings Inc.'s gain/loss on asset sales increased by 83.5% year-over-year, from -$696K to -$115K.
- What is the long-term trend for Organogenesis Holdings Inc.'s gain/loss on asset sales?
- Over 4 years (2021 to 2025), Organogenesis Holdings Inc.'s gain/loss on asset sales has grown at a -39.5% compound annual growth rate (CAGR), from -$1.41M to -$188K.
- What does gain/loss on asset sales mean?
- Gains or losses on asset disposals removed from operating cash flow — the cash impact is captured in investing activities.